254 related articles for article (PubMed ID: 10446997)
1. Frequent loss of expression of the cyclin-dependent kinase inhibitor p27 in epithelial ovarian cancer.
Masciullo V; Sgambato A; Pacilio C; Pucci B; Ferrandina G; Palazzo J; Carbone A; Cittadini A; Mancuso S; Scambia G; Giordano A
Cancer Res; 1999 Aug; 59(15):3790-4. PubMed ID: 10446997
[TBL] [Abstract][Full Text] [Related]
2. The concurrent expression of p27(kip1) and cyclin D1 in epithelial ovarian tumors.
Sui L; Tokuda M; Ohno M; Hatase O; Hando T
Gynecol Oncol; 1999 May; 73(2):202-9. PubMed ID: 10329035
[TBL] [Abstract][Full Text] [Related]
3. Implication of malignancy and prognosis of p27(kip1), Cyclin E, and Cdk2 expression in epithelial ovarian tumors.
Sui L; Dong Y; Ohno M; Sugimoto K; Tai Y; Hando T; Tokuda M
Gynecol Oncol; 2001 Oct; 83(1):56-63. PubMed ID: 11585414
[TBL] [Abstract][Full Text] [Related]
4. Frequent loss of expression of the cyclin-dependent kinase inhibitor p27(Kip1) in estrogen-related Endometrial adenocarcinomas.
Masciullo V; Susini T; Zamparelli A; Bovicelli A; Minimo C; Massi D; Taddei G; Maggiano N; De Iaco P; Ceccaroni M; Bovicelli L; Amunni G; Mancuso S; Scambia G; Giordano A
Clin Cancer Res; 2003 Nov; 9(14):5332-8. PubMed ID: 14614018
[TBL] [Abstract][Full Text] [Related]
5. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
[TBL] [Abstract][Full Text] [Related]
6. Deregulated expression of p27(Kip1) in human breast cancers.
Sgambato A; Zhang YJ; Arber N; Hibshoosh H; Doki Y; Ciaparrone M; Santella RM; Cittadini A; Weinstein IB
Clin Cancer Res; 1997 Oct; 3(10):1879-87. PubMed ID: 9815577
[TBL] [Abstract][Full Text] [Related]
7. Loss of the cyclin-dependent kinase inhibitor p27(Kip1) protein in human prostate cancer correlates with tumor grade.
Guo Y; Sklar GN; Borkowski A; Kyprianou N
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2269-74. PubMed ID: 9815624
[TBL] [Abstract][Full Text] [Related]
8. Antiproliferative function of p27kip1 is frequently inhibited in highly malignant Burkitt's lymphoma cells.
Barnouin K; Fredersdorf S; Eddaoudi A; Mittnacht S; Pan LX; Du MQ; Lu X
Oncogene; 1999 Nov; 18(46):6388-97. PubMed ID: 10597239
[TBL] [Abstract][Full Text] [Related]
9. p27Kip1 expression is associated with clinical outcome in advanced epithelial ovarian cancer: multivariate analysis.
Masciullo V; Ferrandina G; Pucci B; Fanfani F; Lovergine S; Palazzo J; Zannoni G; Mancuso S; Scambia G; Giordano A
Clin Cancer Res; 2000 Dec; 6(12):4816-22. PubMed ID: 11156240
[TBL] [Abstract][Full Text] [Related]
10. Subcellular localization of p27kip1 expression predicts poor prognosis in human ovarian cancer.
Rosen DG; Yang G; Cai KQ; Bast RC; Gershenson DM; Silva EG; Liu J
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):632-7. PubMed ID: 15701850
[TBL] [Abstract][Full Text] [Related]
11. Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines.
Koga H; Sakisaka S; Harada M; Takagi T; Hanada S; Taniguchi E; Kawaguchi T; Sasatomi K; Kimura R; Hashimoto O; Ueno T; Yano H; Kojiro M; Sata M
Hepatology; 2001 May; 33(5):1087-97. PubMed ID: 11343236
[TBL] [Abstract][Full Text] [Related]
12. Expression and subcellular localization of the cyclin-dependent kinase inhibitor p27(Kip1) in epithelial ovarian cancer.
Hurteau JA; Allison BM; Brutkiewicz SA; Goebl MG; Heilman DK; Bigsby RM; Harrington MA
Gynecol Oncol; 2001 Nov; 83(2):292-8. PubMed ID: 11606087
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate.
Liang YC; Lin-Shiau SY; Chen CF; Lin JK
J Cell Biochem; 1999 Oct; 75(1):1-12. PubMed ID: 10462699
[TBL] [Abstract][Full Text] [Related]
14. p27 Expression, a cyclin dependent kinase inhibitor in breast carcinoma.
Barbareschi M
Adv Clin Path; 1999 Oct; 3(4):119-27. PubMed ID: 10936889
[TBL] [Abstract][Full Text] [Related]
15. Acquired expression of p27 is a favorable prognostic indicator in patients with hepatocellular carcinoma.
Fiorentino M; Altimari A; D'Errico A; Cukor B; Barozzi C; Loda M; Grigioni WF
Clin Cancer Res; 2000 Oct; 6(10):3966-72. PubMed ID: 11051245
[TBL] [Abstract][Full Text] [Related]
16. TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells.
Kamesaki H; Nishizawa K; Michaud GY; Cossman J; Kiyono T
J Immunol; 1998 Jan; 160(2):770-7. PubMed ID: 9551912
[TBL] [Abstract][Full Text] [Related]
17. Loss of P27Kip1 expression correlates with tumor grade and with reduced disease-free survival in primary superficial bladder cancers.
Sgambato A; Migaldi M; Faraglia B; Garagnani L; Romano G; De Gaetani C; Ferrari P; Capelli G; Trentini GP; Cittadini A
Cancer Res; 1999 Jul; 59(13):3245-50. PubMed ID: 10397272
[TBL] [Abstract][Full Text] [Related]
18. Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma.
Singh SP; Lipman J; Goldman H; Ellis FH; Aizenman L; Cangi MG; Signoretti S; Chiaur DS; Pagano M; Loda M
Cancer Res; 1998 Apr; 58(8):1730-5. PubMed ID: 9563491
[TBL] [Abstract][Full Text] [Related]
19. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells.
Orend G; Hunter T; Ruoslahti E
Oncogene; 1998 May; 16(20):2575-83. PubMed ID: 9632134
[TBL] [Abstract][Full Text] [Related]
20. Jab1 expression is associated with inverse expression of p27(kip1) and poor prognosis in epithelial ovarian tumors.
Sui L; Dong Y; Ohno M; Watanabe Y; Sugimoto K; Tai Y; Tokuda M
Clin Cancer Res; 2001 Dec; 7(12):4130-5. PubMed ID: 11751512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
